Variant report
Variant | esv3383743 |
---|---|
Chromosome Location | chr4:124418752-124420950 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529072706 | chr4:124418755-124418756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs568827100 | chr4:124418758-124418759 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs574137502 | chr4:124418766-124418767 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs7696421 | chr4:124418788-124418789 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs541599271 | chr4:124418852-124418853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185397269 | chr4:124418898-124418899 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs142404402 | chr4:124418936-124418937 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs115624616 | chr4:124418947-124418948 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs374795889 | chr4:124418954-124418955 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371469062 | chr4:124418975-124418976 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs151263222 | chr4:124418998-124418999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs532366730 | chr4:124419114-124419115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs552328465 | chr4:124419124-124419125 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577622724 | chr4:124419206-124419207 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs140631451 | chr4:124419213-124419214 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs144192037 | chr4:124419238-124419239 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs74976190 | chr4:124419270-124419271 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs111958778 | chr4:124419288-124419289 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs376448171 | chr4:124419318-124419319 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs553797189 | chr4:124419319-124419320 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs72684695 | chr4:124419320-124419321 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs189531837 | chr4:124419322-124419323 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs200390852 | chr4:124419336-124419337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs201712171 | chr4:124419341-124419342 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs199789382 | chr4:124419343-124419344 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs70957558 | chr4:124419344-124419345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs76855416 | chr4:124419345-124419346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs369154865 | chr4:124419356-124419357 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs534998240 | chr4:124419365-124419366 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs563150371 | chr4:124419401-124419402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs7655843 | chr4:124419450-124419451 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs539411900 | chr4:124419492-124419493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs199952833 | chr4:124419493-124419494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs201089157 | chr4:124419538-124419539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs566344662 | chr4:124419540-124419541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs34703974 | chr4:124419558-124419559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs149297940 | chr4:124419563-124419564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs201123995 | chr4:124419580-124419581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs141236574 | chr4:124419582-124419583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs145533328 | chr4:124419596-124419597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs138089740 | chr4:124419604-124419605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs557485220 | chr4:124419637-124419638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs574643735 | chr4:124419653-124419654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs199692276 | chr4:124419662-124419663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs542283264 | chr4:124419687-124419688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs183992816 | chr4:124419708-124419709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs188035169 | chr4:124419721-124419722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs180890943 | chr4:124419725-124419726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs28743084 | chr4:124419727-124419728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs199635258 | chr4:124419745-124419746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Developmental delay | 21147756 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:124416000-124419000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
2 | chr4:124416400-124419000 | Enhancers | Primary monocytes fromperipheralblood | blood |
3 | chr4:124416400-124419400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr4:124416400-124419400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr4:124416800-124418800 | Enhancers | HepG2 | liver |
6 | chr4:124417000-124425200 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
7 | chr4:124417200-124420800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
8 | chr4:124417200-124425200 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
9 | chr4:124417200-124426800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr4:124417400-124425200 | Weak transcription | Psoas Muscle | Psoas |
11 | chr4:124418200-124421800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr4:124418800-124425000 | Weak transcription | HepG2 | liver |
13 | chr4:124419400-124420800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr4:124420800-124421600 | ZNF genes & repeats | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
15 | chr4:124420800-124422400 | ZNF genes & repeats | iPS-18 Cell Line | embryonic stem cell |